Fiaschi, L.; Dragoni, F.; Schiaroli, E.; Bergna, A.; Rossetti, B.; Giammarino, F.; Biba, C.; Gidari, A.; Lai, A.; Nencioni, C.;
et al. Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2. Viruses 2022, 14, 1374.
https://doi.org/10.3390/v14071374
AMA Style
Fiaschi L, Dragoni F, Schiaroli E, Bergna A, Rossetti B, Giammarino F, Biba C, Gidari A, Lai A, Nencioni C,
et al. Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2. Viruses. 2022; 14(7):1374.
https://doi.org/10.3390/v14071374
Chicago/Turabian Style
Fiaschi, Lia, Filippo Dragoni, Elisabetta Schiaroli, Annalisa Bergna, Barbara Rossetti, Federica Giammarino, Camilla Biba, Anna Gidari, Alessia Lai, Cesira Nencioni,
and et al. 2022. "Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2" Viruses 14, no. 7: 1374.
https://doi.org/10.3390/v14071374
APA Style
Fiaschi, L., Dragoni, F., Schiaroli, E., Bergna, A., Rossetti, B., Giammarino, F., Biba, C., Gidari, A., Lai, A., Nencioni, C., Francisci, D., Zazzi, M., & Vicenti, I.
(2022). Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2. Viruses, 14(7), 1374.
https://doi.org/10.3390/v14071374